These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37382078)

  • 21. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
    d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
    Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
    [No Abstract]   [Full Text] [Related]  

  • 22. Krebs von den Lungen-6 (KL-6) is a pathophysiological biomarker of early-stage acute hypersensitivity pneumonitis among pigeon fanciers.
    Ji Y; Bourke SJ; Spears M; Wain LV; Boyd G; Lynch PP; Cunningham M; Boyd K; Donnelly I; Kohno N; McSharry C
    Clin Exp Allergy; 2020 Dec; 50(12):1391-1399. PubMed ID: 32966647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.
    Xue M; Zheng P; Bian X; Huang Z; Huang H; Zeng Y; Hu H; Liu X; Zhou L; Sun B; Wu JL; Zhong N
    Biosci Trends; 2020 Sep; 14(4):290-296. PubMed ID: 32565512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
    Iwata H; Haga N; Sugai T; Fujita Y
    J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis.
    Choi MG; Choi SM; Lee JH; Kim JY; Song JW
    Respir Res; 2022 Dec; 23(1):334. PubMed ID: 36494685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy.
    d'Alessandro M; Bergantini L; Cameli P; Pieroni M; Refini RM; Sestini P; Bargagli E
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities.
    Wakamoto H; Sano N; Yano Y; Sakai S; Kikuchi T; Fukuda M; Morimoto T; Ishii E
    J Pediatr; 2015 Nov; 167(5):1136-42. PubMed ID: 26382626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis.
    d'Alessandro M; Bergantini L; Cameli P; Lanzarone N; Antonietta Mazzei M; Alonzi V; Sestini P; Bargagli E
    Eur J Clin Invest; 2020 Apr; ():e13242. PubMed ID: 32307698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Asian Pac J Cancer Prev; 2017 Jan; 18(1):287-291. PubMed ID: 28240848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
    Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
    Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
    d'Alessandro M; Cameli P; Refini RM; Bergantini L; Alonzi V; Lanzarone N; Bennett D; Rana GD; Montagnani F; Scolletta S; Franchi F; Frediani B; Valente S; Mazzei MA; Bonella F; Bargagli E
    J Med Virol; 2020 Oct; 92(10):2216-2220. PubMed ID: 32470148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
    Kuwana M; Shirai Y; Takeuchi T
    J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Krebs von den Lungen-6, a promising marker in evaluating the severity of interstitial lung disease in Egyptian rheumatoid arthritis patients.
    Hammoda RM; Salah-ElDin H; El-Gharbawy NH; Ragab D
    Egypt J Immunol; 2021 Oct; 28(4):241-249. PubMed ID: 34882373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis.
    Janssen R; Sato H; Grutters JC; Bernard A; van Velzen-Blad H; du Bois RM; van den Bosch JM
    Chest; 2003 Dec; 124(6):2119-25. PubMed ID: 14665489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019.
    Chen H; Qin R; Huang Z; Luo W; Zheng P; Huang H; Hu H; Wang H; Sun B
    Cytokine; 2021 Dec; 148():155513. PubMed ID: 34507246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
    Shirai Y; Fukue R; Kaneko Y; Kuwana M
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.
    Jiang D; Xiao H; Dong R; Geng J; Xie B; Ren Y; Dai H
    Clin Respir J; 2022 Mar; 16(3):234-243. PubMed ID: 35081277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Matuszewski M; Szarpak L; Rafique Z; Peacock FW; Pruc M; Szwed P; Chirico F; Navolokina A; Ladny JR; Denegri A
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.